Tuning porosity of macroporous hydrogels enables rapid rates of stress relaxation and promotes cell expansion and migration.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
05 Nov 2024
Historique:
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: ppublish

Résumé

Extracellular matrix (ECM) viscoelasticity broadly regulates cell behavior. While hydrogels can approximate the viscoelasticity of native ECM, it remains challenging to recapitulate the rapid stress relaxation observed in many tissues without limiting the mechanical stability of the hydrogel. Here, we develop macroporous alginate hydrogels that have an order of magnitude increase in the rate of stress relaxation as compared to bulk hydrogels. The increased rate of stress relaxation occurs across a wide range of polymer molecular weights (MWs), which enables the use of high MW polymer for improved mechanical stability of the hydrogel. The rate of stress relaxation in macroporous hydrogels depends on the volume fraction of pores and the concentration of bovine serum albumin, which is added to the hydrogels to stabilize the macroporous structure during gelation. Relative to cell spheroids encapsulated in bulk hydrogels, spheroids in macroporous hydrogels have a significantly larger area and smaller circularity because of increased cell migration. A computational model provides a framework for the relationship between the macroporous architecture and morphogenesis of encapsulated spheroids that is consistent with experimental observations. Taken together, these findings elucidate the relationship between macroporous hydrogel architecture and stress relaxation and help to inform the design of macroporous hydrogels for materials-based cell therapies.

Identifiants

pubmed: 39467139
doi: 10.1073/pnas.2410806121
doi:

Substances chimiques

Hydrogels 0
Alginates 0
Serum Albumin, Bovine 27432CM55Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2410806121

Subventions

Organisme : HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ID : F32DK134115
Organisme : HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)
ID : T32EB016652
Organisme : Harvard MRSEC
ID : DMR-2011754
Organisme : Wellcome Leap HOPE
ID : none
Organisme : SMA Foundation
ID : none
Organisme : SERB-India
ID : MTR/2022/000232
Organisme : SERB-India
ID : CRG/2023/007056-G
Organisme : TCS Foundation
ID : TCS/17/23-24/P49

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Bryan A Nerger (BA)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Kirti Kashyap (K)

Department of Physics, Indian Institute of Technology Hyderabad, Sangareddy, Telangana 502285, India.

Brendan T Deveney (BT)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Junzhe Lou (J)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Blake F Hanan (BF)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Qi Liu (Q)

Whitehead Institute for Biomedical Research, Cambridge, MA 02142.

Andrew Khalil (A)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.
Whitehead Institute for Biomedical Research, Cambridge, MA 02142.

Tenzin Lungjangwa (T)

Whitehead Institute for Biomedical Research, Cambridge, MA 02142.

Maria Cheriyan (M)

Harvard College, Harvard University, Cambridge, MA 02138.

Anupam Gupta (A)

Department of Physics, Indian Institute of Technology Hyderabad, Sangareddy, Telangana 502285, India.

Rudolf Jaenisch (R)

Whitehead Institute for Biomedical Research, Cambridge, MA 02142.
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142.

David A Weitz (DA)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.
Department of Physics, Harvard University, Cambridge, MA 02138.

L Mahadevan (L)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Department of Physics, Harvard University, Cambridge, MA 02138.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138.

David J Mooney (DJ)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH